BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33712844)

  • 1. Cost-effectiveness of a mobile technology-enabled primary care intervention for cardiovascular disease risk management in rural Indonesia.
    Angell B; Lung T; Praveen D; Maharani A; Sujarwoto S; Palagyi A; Oceandy D; Tampubolon G; Patel A; Jan S
    Health Policy Plan; 2021 May; 36(4):435-443. PubMed ID: 33712844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Multifaceted Mobile Technology-Enabled Primary Care Intervention With Cardiovascular Disease Risk Management in Rural Indonesia.
    Patel A; Praveen D; Maharani A; Oceandy D; Pilard Q; Kohli MPS; Sujarwoto S; Tampubolon G
    JAMA Cardiol; 2019 Oct; 4(10):978-986. PubMed ID: 31461123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
    Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
    BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
    Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
    Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A computer-guided quality improvement tool for primary health care: cost-effectiveness analysis based on TORPEDO trial data.
    Patel B; Peiris DP; Patel A; Jan S; Harris MF; Usherwood T; Panaretto K; Lung T
    Med J Aust; 2020 Jul; 213(2):73-78. PubMed ID: 32594567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas.
    Wang H; Kenkel D; Graham ML; Paul LC; Folta SC; Nelson ME; Strogatz D; Seguin RA
    BMC Health Serv Res; 2019 May; 19(1):315. PubMed ID: 31096977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of a Multicomponent Primary Care Intervention for Hypertension.
    Chay J; Jafar TH; Su RJ; Shirore RM; Tan NC; Finkelstein EA
    J Am Heart Assoc; 2024 Apr; 13(8):e033631. PubMed ID: 38606776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
    Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
    Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a statewide public health intervention to reduce cardiovascular disease risk.
    Smith L; Atherly A; Campbell J; Flattery N; Coronel S; Krantz M
    BMC Public Health; 2019 Sep; 19(1):1234. PubMed ID: 31492118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].
    Si YQ; Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Liu JJ; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):443-449. PubMed ID: 29930411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program.
    Rosendaal NT; Hendriks ME; Verhagen MD; Bolarinwa OA; Sanya EO; Kolo PM; Adenusi P; Agbede K; van Eck D; Tan SS; Akande TM; Redekop W; Schultsz C; Gomez GB
    PLoS One; 2016; 11(6):e0157925. PubMed ID: 27348310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I).
    Hendriks M; Brewster L; Wit F; Bolarinwa OA; Odusola AO; Redekop W; Bindraban N; Vollaard A; Alli S; Adenusi P; Agbede K; Akande T; Lange J; Schultsz C
    BMC Public Health; 2011 Mar; 11():186. PubMed ID: 21439057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study.
    Maharani A; Sujarwoto ; Praveen D; Oceandy D; Tampubolon G; Patel A
    PLoS One; 2019; 14(4):e0215219. PubMed ID: 31039155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria.
    Gomez GB; Foster N; Brals D; Nelissen HE; Bolarinwa OA; Hendriks ME; Boers AC; van Eck D; Rosendaal N; Adenusi P; Agbede K; Akande TM; Boele van Hensbroek M; Wit FW; Hankins CA; Schultsz C
    PLoS One; 2015; 10(9):e0139048. PubMed ID: 26413788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness and budget impact of the community-based management of hypertension in Nepal study (COBIN): a retrospective analysis.
    Krishnan A; Finkelstein EA; Kallestrup P; Karki A; Olsen MH; Neupane D
    Lancet Glob Health; 2019 Oct; 7(10):e1367-e1374. PubMed ID: 31537367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study.
    Lin JK; Moran AE; Bibbins-Domingo K; Falase B; Pedroza Tobias A; Mandke CN; Kazi DS
    Lancet Glob Health; 2019 Oct; 7(10):e1346-e1358. PubMed ID: 31477544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost Effectiveness of Implementing Integrated Management of Neonatal and Childhood Illnesses Program in District Faridabad, India.
    Prinja S; Bahuguna P; Mohan P; Mazumder S; Taneja S; Bhandari N; van den Hombergh H; Kumar R
    PLoS One; 2016; 11(1):e0145043. PubMed ID: 26727369
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.